HistoGeneX PD-L1 IHC and CD8 Work in ABACUS Trial Presented at ASCO 2018
Abacus Trial presented at ASCO 2018: Neo-adjuvant immunotherapy in bladder cancer. Complete pathological response in bladder wall is related with the PDL1 status and opens opportunities to understand biological mechanism of action. Thomas Powles (MD, Barts Cancer Institute, Queen Mary…